Science and Research

USP10/GSK3

Activating mutations in PIK3CA, the gene encoding the catalytic p110

  • Kumari, N.
  • Wright, S. C.
  • Witham, C. M.
  • Monserrat, L.
  • Palafox, M.
  • Richard, J. L.
  • Costa, C.
  • Elkabets, M.
  • Agostino, M.
  • Klemm, T.
  • Eccles, M.
  • Garnham, A.
  • Wu, T.
  • Nilsson, J. A.
  • Walz, N.
  • Venugopal, V.
  • Cerra, A.
  • Vasilevski, N.
  • Bridgeman, S.
  • Bassi, S.
  • Saei, A.
  • Helal, M.
  • Neundorf, P.
  • Riedel, A.
  • Rosenfeldt, M.
  • Gill, J.
  • Pahor, N.
  • Hartmann, O.
  • Chung, J.
  • Sidhu, S. S.
  • Moderau, N.
  • Jha, S.
  • Rodon, J.
  • Diefenbacher, M. E.
  • Komander, D.
  • Serra, V.
  • Eichhorn, P. J. A.

Keywords

  • Humans
  • *PTEN Phosphohydrolase/metabolism/genetics/antagonists & inhibitors
  • *Breast Neoplasms/drug therapy/genetics/pathology/metabolism/enzymology
  • Female
  • *Drug Resistance, Neoplasm
  • *Glycogen Synthase Kinase 3 beta/metabolism/genetics
  • Animals
  • Mice
  • *Ubiquitin Thiolesterase/metabolism/genetics
  • *Phosphoinositide-3 Kinase Inhibitors/pharmacology
  • Cell Line, Tumor
  • Signal Transduction/drug effects
  • Class I Phosphatidylinositol 3-Kinases/genetics/metabolism/antagonists &
  • inhibitors
  • *Neoplasm Proteins/metabolism/genetics/antagonists & inhibitors
  • Phosphatidylinositol 3-Kinases/metabolism/genetics
  • Breast cancer
  • Cell biology
  • Oncology
  • Signal transduction
  • Ubiquitin-proteosome system
Publication details
DOI: 10.1172/jci180927
Journal: J Clin Invest
Number: 22
Work Type: Original
Location: CPC-M
Disease Area: LC
Partner / Member: HMGU
Access-Number: 40991650


chevron-down